"Banks Of 3rd Party Donor-Derived Virus-Specific T-Cells of Defined Epitope Specificity and HLA Restriction Providing “Off-The-Shelf” Treatment for Drug-Refractory EBV+ Lymphomas and CMV Infections in Marrow and Solid Organ Transplant Recipients," presented by Richard J. O'Reilly, MD. Dr. O’Reilly is the Claire L. Tow Chair in Pediatric Oncology Research and former Chair of the Department of Pediatrics at Memorial Sloan Kettering Cancer Center. As Chief of the Bone Marrow Transplantation Services in both the Departments of Pediatrics and Medicine, Dr. O'Reilly pioneered transplantation approaches for patients who lack HLA matched siblings.#cancer #cancerresearch #oncology

8th Annual Karl G. Blume, MD, Memorial Lecture
Stanford Cancer Institute-Frontiers in Oncology Seminar

Learn more about our Frontiers in Oncology series:
[ Ссылка ]
Learn more about the Stanford Cancer Institute: [ Ссылка ]

Follow the Stanford Cancer Institute
LinkedIn: [ Ссылка ]
Twitter: [ Ссылка ]
Subscribe to the Stanford Cancer Institute: [ Ссылка ]

свернуть